Trial Profile
Creatine therapy for Huntington's disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Creatine monohydrate (Primary)
- Indications Huntington's disease
- Focus Therapeutic Use
- Acronyms CREST-HD
- 01 Sep 2006 Status change
- 02 Oct 2005 New trial record.